|
|
|
|
| LEADER |
00000cam a2200000Mi 4500 |
| 001 |
EBSCO_on1125188447 |
| 003 |
OCoLC |
| 005 |
20231017213018.0 |
| 006 |
m o d |
| 007 |
cr ||||||||||| |
| 008 |
191022s2019 gw od z000 0 eng d |
| 040 |
|
|
|a DEGRU
|b eng
|e rda
|e pn
|c DEGRU
|d N$T
|d OCLCQ
|d OCLCF
|d OCLCO
|d OCLCQ
|d DEGRU
|
| 020 |
|
|
|a 3110851725
|
| 020 |
|
|
|a 9783110851724
|q (electronic bk.)
|
| 024 |
7 |
|
|a 10.1515/9783110851724
|2 doi
|
| 029 |
1 |
|
|a AU@
|b 000066189363
|
| 035 |
|
|
|a (OCoLC)1125188447
|
| 050 |
|
4 |
|a RC658.3
|
| 072 |
|
7 |
|a MED027000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616.47
|2 23
|
| 049 |
|
|
|a UAMI
|
| 100 |
1 |
|
|a Nortier, J. W. R.,
|e author.
|
| 245 |
1 |
0 |
|a Adjunctive Medical Therapy for Acromegalic Patients /
|c J.W.R. Nortier.
|
| 250 |
|
|
|a Reprint 2019.
|
| 264 |
|
1 |
|a Berlin ;
|a Boston :
|b De Gruyter Mouton,
|c [2019]
|
| 264 |
|
4 |
|c ©1984
|
| 300 |
|
|
|a 1 online resource (x, 91 pages) :
|b Num. tables
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
|
|
|a text file
|b PDF
|2 rda
|
| 490 |
0 |
|
|a Clinical research series ;
|v 2
|
| 505 |
0 |
0 |
|t Frontmatter --
|t List of abbreviations --
|t Contents --
|t CHAPTER I. Introduction --
|t CHAPTER II. Plasma growth hormone suppressive effect of bromocriptine in acromegaly. Evaluation by plasma GH day profiles and plasma GH concentrations during oral glucose tolerance tests /
|r Nortier, J.W.R. / Croughs, R.J.M. / Thijssen, J.H.H. / Schwarz, F. --
|t CHAPTER III. Changes in plasma GH levels and clinical activity during bromocriptine therapy in acromegaly. The value of predictive tests /
|r Nortier, J.W.R. / Croughs, R.J.M. / Donker, G.H. / Thijssen, J.H.H. / Schwarz, F. --
|t CHAPTER IV. Bromocriptine therapy in acromegaly: effects on plasma GH levels, somatomedin-C levels and clinical activity /
|r Nortier, J.W.R. / Croughs, R.J.M. / Thijssen, J.H.H. / Schwarz, F. --
|t CHAPTER V. Gel filtration studies of plasma growth hormone in bromocriptine treated acromegaly: correlations with somatomedin-C and clinical response /
|r Nortier, J.W.R. / Croughs, R.J.M. / Donker, G.H. / Thijssen, J.H.H. / Schwarz, F. --
|t CHAPTER VI. No acute effect of pimozide on the plasma GH levels in acromegaly /
|r Nortier, J.W.R. / Croughs, R.J.M. / Donker, G.H. / Thijssen, J.H.H. / Schwarz, F. --
|t CHAPTER VII. Long-term follow-up of five untreated acromegalic patients /
|r Nortier, J.W.R. / Croughs, R.J.M. / Thijssen, J.H.H. / Schwarz, F. --
|t CHAPTER VIII. General discussion --
|t Summary
|
| 546 |
|
|
|a In English.
|
| 588 |
0 |
|
|a Online resource; title from PDF title page (publisher's Web site, viewed 22. Okt 2019).
|
| 590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
| 650 |
|
0 |
|a Acromegaly.
|
| 650 |
|
0 |
|a Bromocriptine
|x Therapeutic use.
|
| 650 |
|
0 |
|a Somatotropin.
|
| 650 |
|
2 |
|a Acromegaly
|
| 650 |
|
2 |
|a Growth Hormone
|
| 650 |
|
6 |
|a Acromégalie.
|
| 650 |
|
6 |
|a Bromocriptine
|x Emploi en thérapeutique.
|
| 650 |
|
6 |
|a Somatotrophine.
|
| 650 |
|
7 |
|a MEDICAL
|x Endocrinology & Metabolism.
|2 bisacsh
|
| 650 |
|
7 |
|a Acromegaly.
|2 fast
|0 (OCoLC)fst00796086
|
| 650 |
|
7 |
|a Somatotropin.
|2 fast
|0 (OCoLC)fst01125752
|
| 776 |
0 |
8 |
|i Print version:
|z 9783110133653
|
| 856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2266610
|z Texto completo
|
| 938 |
|
|
|a De Gruyter
|b DEGR
|n 9783110851724
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 2266610
|
| 994 |
|
|
|a 92
|b IZTAP
|
